Enzo Biochem CEO Elazar Rabbani's 2018 pay slips 4% to $1.5M

Enzo Biochem reports 2018 executive compensation

Enzo Biochem reported fiscal year 2018 executive compensation information on November 21, 2018.

In 2018, five executives at Enzo Biochem received on average a compensation package of $837K, a 3% decrease compared to previous year.

Average pay of disclosed executives at Enzo Biochem

Elazar Rabbani, Chief Executive Officer, received $1.5M in total, which decreased by 4% compared to 2017. 41.38% of Rabbani's compensation, or $611K, was in salary. Rabbani also received $500K in non-equity incentive plan, $137.3K in option awards, $44.2K in stock awards, as well as $184.1K in other compensation.

Barry W. Weiner, Chief Financial Officer, received a compensation package of $1.2M, which decreased by 1% compared to previous year. 43.47% of the compensation package, or $542K, was in salary.

Bruce A. Dey, Vice President of Sales, Enzo Clinical Labs, earned $496.5K in 2018, a 12% decrease compared to previous year.

James M. O'Brien, Executive Vice President of Finance, received $494.7K in 2018, which decreases by 1% compared to 2017.

Dieter Schapfel, Chief Medical Director, Enzo Clinical Labs, earned $470.1K in 2018, a 4% increase compared to previous year.

Enzo Biochem's fiscal year ends on July 31.